Christine Garrett
Corporate Officer/Principal chez LEO Pharma A/S
Postes actifs de Christine Garrett
Sociétés | Poste | Début | Fin |
---|---|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
Historique de carrière de Christine Garrett
Anciens postes connus de Christine Garrett
Sociétés | Poste | Début | Fin |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
LENZ THERAPEUTICS, INC. | Directeur des opérations | 01/01/2022 | - |
Responsable des Ressources Humaines | 01/01/2022 | - | |
Public Communications Contact | - | - |
Formation de Christine Garrett
Rochester Institute of Technology | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Danemark | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Human Resources Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Entreprise privées | 2 |
---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Christine Garrett
- Expérience